carnosine has been researched along with Complications of Diabetes Mellitus in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Billacura, MP; Boocock, DJ; Caton, PW; Colombo, SL; Coveney, C; Doig, CL; Foulds, GA; Hanna, K; Jackisch, L; Lavilla, CJ; McTernan, PG; Miles, AK; Murphy, A; Sale, C; Sayers, SR; Tan, A; Turner, MD | 1 |
| Büttner, M; Fleming, T; Kroll, J; Li, X; Morgenstern, J; Nawroth, PP; Peters, V; Poschet, G; Poth, T; Schmitt, CP; Schmöhl, F; Volk, N; Weigand, T | 1 |
| Fantauzzi, CB; Iacobini, C; Menini, S; Pugliese, G | 1 |
| Babizhayev, MA; Deyev, AI; Lankin, VZ; Savel'Yeva, EL; Yegorov, YE | 2 |
| Babizhayev, MA; Guiotto, A; Kasus-Jacobi, A | 1 |
| Hipkiss, AR | 1 |
| Harding, JJ; Li, MY; Shi, Q; Yan, H | 1 |
| Cooper, ME; Forbes, JM; Sourris, KC | 1 |
3 review(s) available for carnosine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
L-carnosine and its Derivatives as New Therapeutic Agents for the Prevention and Treatment of Vascular Complications of Diabetes.
Topics: Atherosclerosis; Carnosine; Diabetes Complications; Diabetes Mellitus; Glycation End Products, Advanced; Glycosylation; Humans; Oxidation-Reduction; Oxidative Stress | 2020 |
Diabetes mellitus: novel insights, analysis and interpretation of pathophysiology and complications management with imidazole-containing peptidomimetic antioxidants.
Topics: Animals; Antioxidants; Carnosine; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Design; Humans; Hyperglycemia; Imidazoles; Patents as Topic; Peptidomimetics | 2013 |
Therapeutic interruption of advanced glycation in diabetic nephropathy: do all roads lead to Rome?
Topics: Carnosine; Diabetes Complications; Diabetic Neuropathies; Glycation End Products, Advanced; Humans; Reactive Oxygen Species; Thiazoles | 2008 |
2 trial(s) available for carnosine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications.
Topics: Aged; Aged, 80 and over; Aldehydes; Aminooxyacetic Acid; Animals; Biological Availability; Carnosine; Cataract; Cornea; Cross-Over Studies; Diabetes Complications; Disease Models, Animal; Drug Administration Schedule; Drug Delivery Systems; Drug Synergism; Female; Glycosylation; Histidine; Humans; Hydrazines; Lubricants; Male; Middle Aged; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Ophthalmoscopy; Rabbits | 2009 |
Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and
Topics: Adolescent; Adult; Aged; Carnosine; Ceruloplasmin; Dermatologic Agents; Diabetes Complications; Double-Blind Method; Female; Free Radicals; Glycation End Products, Advanced; Humans; Lysine; Middle Aged; Oxidative Stress; Pyruvaldehyde; Schiff Bases; Skin Aging; Skin Diseases; Young Adult | 2012 |
4 other study(ies) available for carnosine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Carnosine protects stimulus-secretion coupling through prevention of protein carbonyl adduction events in cells under metabolic stress.
Topics: Animals; Carnosine; Diabetes Complications; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Mice; Oxidative Stress; Protein Carbonylation | 2021 |
CNDP1 knockout in zebrafish alters the amino acid metabolism, restrains weight gain, but does not protect from diabetic complications.
Topics: Amino Acids; Animals; Carnosine; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptidases; Gene Knockout Techniques; Kidney; Weight Gain; Zebrafish | 2019 |
Carnosine, diabetes and Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Carnosine; Diabetes Complications; Humans | 2009 |
Effect of a combination of carnosine and aspirin eye drops on streptozotocin -- induced diabetic cataract in rats.
Topics: Animals; Aspirin; Blood Glucose; Body Weight; Carnosine; Cataract; Diabetes Complications; Drinking Behavior; Drug Therapy, Combination; Feeding Behavior; Glycosuria; Lens, Crystalline; Male; Ophthalmic Solutions; Rats; Rats, Sprague-Dawley; Solubility; Streptozocin; Sulfhydryl Compounds; Time Factors | 2009 |